Literature DB >> 11703993

Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program.

V Vaccarino1, A K Berger, J Abramson, H R Black, J F Setaro, J A Davey, H M Krumholz.   

Abstract

Pulse pressure has been related to higher risk of cardiovascular events in older persons. Isolated systolic hypertension is common among the elderly and is accompanied by elevated pulse pressure. Treatment of isolated systolic hypertension may further increase pulse pressure if diastolic pressure is lowered to a greater extent than systolic pressure. Little is known regarding pulse pressure as a predictor of cardiovascular outcomes in elderly persons with isolated systolic hypertension, and the influence of treatment on the pulse pressure effect. We assessed the relation between pulse pressure, measured throughout the follow-up period, and the incidence of coronary heart disease (CHD), heart failure (HF), and stroke in 4,632 participants in the Systolic Hypertension in the Elderly Program, a 5-year randomized, placebo-controlled clinical trial of treatment of isolated systolic hypertension in older adults. In the treatment group, a 10-mm Hg increase in pulse pressure was associated with a statistically significant 32% increase in risk of HF and a 24% increase in risk of stroke after controlling for systolic blood pressure and other known risk factors, as well as with a 23% increase in risk of HF and a 19% increase in risk of stroke after controlling for diastolic blood pressure and other risk factors. Pulse pressure was not significantly associated with HF or stroke in the placebo group, nor with incidence of CHD in either the placebo or treatment group. These results suggest that pulse pressure is a useful marker of risk for HF and stroke among older adults being treated for isolated systolic hypertension.

Entities:  

Mesh:

Year:  2001        PMID: 11703993     DOI: 10.1016/s0002-9149(01)01974-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

1.  Pulse pressure and subclinical peripheral artery disease.

Authors:  P Korhonen; H Kautiainen; P Aarnio
Journal:  J Hum Hypertens       Date:  2013-10-17       Impact factor: 3.012

2.  Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Lama Ghazi; Monika M Safford; Yulia Khodneva; Wesley T O'Neal; Elsayed Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-06-07

3.  2017 ACC/AHA blood pressure classification and incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yifei Lu; Shoshana H Ballew; Hirofumi Tanaka; Moyses Szklo; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  Eur J Prev Cardiol       Date:  2019-07-30       Impact factor: 7.804

4.  Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites.

Authors:  Thais Coutinho; Stephen T Turner; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2011-10-20       Impact factor: 2.689

5.  Investigation of elastic features of aorta and color M-mode flow propagation velocity (APV) of descending aorta in the patients with ischemic and non-ischemic dilated cardiomyopathy.

Authors:  Mesut Gitmez
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-24       Impact factor: 2.357

6.  Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial.

Authors:  Elaine Ku; Rebecca Scherzer; Michelle C Odden; Michael Shlipak; Carole L White; Thalia S Field; Oscar Benavente; Pablo E Pergola; Carmen A Peralta
Journal:  Blood Press       Date:  2017-09-27       Impact factor: 2.835

7.  Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation.

Authors:  Zhongwen Xie; Wen Su; Shu Liu; Guogang Zhao; Karyn Esser; Elizabeth A Schroder; Mellani Lefta; Harald M Stauss; Zhenheng Guo; Ming Cui Gong
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

Review 8.  The J-curve in hypertension.

Authors:  John Cruickshank
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 9.  Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease.

Authors:  Susan J Zieman; David A Kass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?

Authors:  Ashraf Fayad; Homer Yang
Journal:  Curr Cardiol Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.